Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluate the Effect of Several Risk Factors That Are Likely to Influence the Immunogenicity of GSK Biologicals' Combined Hepatitis A & B Vaccine, vs Separately Administered Monovalent Hepatitis A and Hepatitis B Vaccines

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00289731
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:30.669992+00:00
Published At
2018-10-03T00:00:00+00:00
Record Updated At
2019-11-15
Results Posted At
2018-10-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hepatitis B", "Hepatitis A"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-11-15"
protocolSection.identificationModule.nctId
"NCT00289731"
protocolSection.identificationModule.officialTitle
"Evaluate the Effect of Several Risk Factors That Are Likely to Influence the Immunogenicity of GSK Biologicals\u0027 Combined Hepatitis A \u0026 B Vaccine, vs Separately Administered Monovalent Hepatitis A and Hepatitis B Vaccines"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-10-03"

Study condition terms

  • Hepatitis B (protocolSection.conditionsModule.conditions)
  • Hepatitis A (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.